LLY241122P675000
- 0.01
- -0.09-90.00%
Eli Lilly and Co Newsroom
Jim Cramer on Eli Lilly and Company (LLY): 'It's Valuable'
The EU may unconditionally approve novo-nordisk a/s (NVO.US) parent company's acquisition of catalent (CTLT.US).
The European Commission may unconditionally approve Novo Nordisk A/S (NVO.US) parent company Novo Holdings' $16.5 billion acquisition of US contract pharmaceutical company Catalent (CTLT.US).
The Trader: Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barron's
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Sanofi Becomes Latest Drugmaker to Challenge HHS Over 340B Drug-discount Program
Novo Nordisk (NVO.US) has signed a contract with Ypsomed to manufacture the next generation of weight-loss injection pens.
Novo Nordisk A/S has announced that it has signed a contract with Ypsomed to produce the next generation of weight-loss pen.
Eli Lilly and Co (LLY.US) has submitted a fourth application for the new drug "Tirzepatide" in China.
eli lilly and co (LLY.US) has received acceptance for the new indication上市申请 of its blockbuster drug GIP/GLP-1 receptor dual agonist tirzepatide injection, though specific indications have not yet been disclosed.
Novo Nordisk Said to Have Contracted Ypsomed to Make Next Gen Obesity Drug's Pens
Goldman Sachs: Eli Lilly and Company (LLY) Is A Top Growth Investor Stock
Amgen (AMGN.US) weight loss drug is poised for launch, and Wall Street is eagerly awaiting the research results.
The upcoming data from Amgen's experimental weight loss drug MariTide mid-term study will reveal the comparison of this drug with the GLP-1 drugs sold by Eli Lilly and Co and Novo-Nordisk A/S.
In 2025, the global medical care industry is expected to welcome an investment boom, with a focus on Biotech.
Jefferies Financial stated that investor sentiment in the global medical care industry has significantly warmed.
Shares Of Hims & Hers Health See Volume; Traders Circulate Court Filing Regarding Shortage Of Lilly's Tirzepatide Shortage, Parties Agree To Maintain Stay As Ordered By Court In October 2024, With Joint Status Report Due By December 19, 2024, Or...
Hims & Hers Closes up 10% as Lilly Tirzepatide Compounding Dispute Resolution Delayed
Optimism Over Global Healthcare Sector Rises: Jefferies
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Nvidia Insiders Plan Big Stock Sales. CEO Jensen Huang Isn't One of Them.
Wells Fargo Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,000
Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop -- Barrons.com
Following the US Secretary of Health, Trump's nomination for the FDA Commissioner seems to be another anti-vaccine advocate.
Makari is a surgeon who opposes overtreatment, advocates for re-evaluating hormone replacement therapy, and reducing the overuse of antibiotics.
Trading volume TOP 20 | microstrategy's market cap surpasses 100 billion US dollars; Target falls over 21%, lowers full-year guidance.
On Wednesday, Tesla, ranked 3rd in trading volume on the US stock market, fell by 1.15%, with a trading volume of 22.449 billion USD; Eli Lilly and Co, ranked 11th, rose by 3.25%, with a trading volume of 3.863 billion USD; Super micro computer, ranked 18th, fell by 8.74%, with a trading volume of 2.708 billion USD.